| Glutality Provider Group Of California Pc | |
|
7250 Redwood Blvd Ste 300 Novato CA 94945-3269 | |
| (561) 678-2026 | |
| (561) 423-9249 |
| Full Name | Glutality Provider Group Of California Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 7250 Redwood Blvd Ste 300, Novato, California |
| Authorized Official Name and Position | Mark Mitchell (OWNER) |
| Authorized Official Contact | 5616782026 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Glutality Provider Group Of California Pc 401 Fairway Dr Ste 200 Deerfield Beach FL 33441-1800 Ph: (561) 678-2026 | Glutality Provider Group Of California Pc 7250 Redwood Blvd Ste 300 Novato CA 94945-3269 Ph: (561) 678-2026 |
| NPI Number | 1235843723 |
|---|---|
| Provider Enumeration Date | 01/09/2023 |
| Last Update Date | 01/09/2023 |
| Medicare PECOS PAC ID | 3870957046 |
|---|---|
| Medicare Enrollment ID | O20230907001074 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235843723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Corey Brown |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487944617 PECOS PAC ID: 8224281019 Enrollment ID: I20131112000462 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Anshul M Gandhi |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1396177564 PECOS PAC ID: 4981832185 Enrollment ID: I20161003002050 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Nicholas A Raubitschek |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1093101248 PECOS PAC ID: 6002122124 Enrollment ID: I20180911002459 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Ellena Lois Boddie |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689673790 PECOS PAC ID: 0840399515 Enrollment ID: I20210420001712 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Daniel G Funsch |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1023471547 PECOS PAC ID: 2365789039 Enrollment ID: I20220714002140 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Mark Mitchell |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1003833633 PECOS PAC ID: 2264333632 Enrollment ID: I20231027001988 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Erik Deede |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1821036112 PECOS PAC ID: 5092889808 Enrollment ID: I20231115001967 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
| Provider Name | Robert Edward Hurd |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720015787 PECOS PAC ID: 4082895461 Enrollment ID: I20231127002134 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.
A new study reveals that between 1992 and 2008 the proportion of substance abuse treatment admissions involving older Americans (aged 50 and older) nearly doubled - from 6.6 percent of all admissions in 1992 to 12.2 percent in 2008. The study, sponsored by the Substance Abuse and Mental Health Services Administration, also shows a sharp rise during this period in the proportion of older Americans admissions related to illicit drug abuse - even though alcohol abuse is still the leading cause for admissions involving this age group.
Today the national food safety law firm of Ron Simon & Associates, along with local counsel Janet, Jenner & Suggs, filed a lawsuit stemming from salmonella-contaminated food served by the Tarheel Q located in North Carolina on U.S. 64 West in Lexington.
A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
› Verified 3 days ago
Marin Community Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 6100 Redwood Blvd, Novato, CA 94945 Phone: 415-448-1500 Fax: 415-798-3198 | |
Matrix Parent Netwrok And Resource Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 94 Galli Dr, Suite C, Novato, CA 94949 Phone: 415-884-3535 | |
N/a Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1324 Grant Ave, Novato, CA 94945 Phone: 415-892-3300 Fax: 415-897-0079 | |
Veterans Administration Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7 Lavenham Rd, Novato, CA 94949 Phone: 415-218-1435 | |
Novato Internal Medicine Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 165 Rowland Way, Suite 201, Novato, CA 94945 Phone: 415-897-3174 Fax: 415-892-9589 | |
Aspire Hospitalist Management Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 165 Rowland Way, Novato, CA 94945 Phone: 415-990-7901 |